The metabolism of cyclamate to cyclohexylamine in humans during long-term administration

Toxicology and Applied Pharmacology

Volumn 196, Issue 3, 2004, Pages 367-380

  Renwick, A G ^a   Thompson, J P ^a,b   O'Shaughnessy, M ^a   Walter, E J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Acceptable daily intake; Cyclamate; Cyclamate metabolism; Cyclohexanesulphamic acid; Cyclohexylamine; Cyclohexylamine formation; Cyclohexylsulphamic acid; Gut microflora; Human variability

Indexed keywords

CALCIUM DERIVATIVE; CYCLAMATE CALCIUM; CYCLAMATE SODIUM; CYCLOHEXYLAMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LONG TERM EXPOSURE; MALE; METABOLISM; NORMAL HUMAN; QUANTITATIVE ANALYSIS; STEADY STATE; URINALYSIS; URINARY EXCRETION; VARIANCE;

ADULT; CYCLAMATES; CYCLOHEXYLAMINES; FEMALE; HUMANS; MALE; MIDDLE AGED; TABLETS; TIME FACTORS;

EID: 1942471746     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.01.013     Document Type: Article

References (29)

1. Bopp B.A., Sonders R.C., Kesterson J.W. Toxicological aspects of cyclamate and cyclohexylamine. CRC Crit. Rev. Toxicol. 16:1986;213-306.
2. Buss N.E., Renwick A.G., Donaldson K.M., George C.F. The metabolism of cyclamate to cyclohexylamine and its cardiovascular consequences in human volunteers. Toxicol. Appl. Pharmacol. 115:1992;199-210.
3. Creasy D.M., Ford G.R., Gray T.J.B. The morphogenesis of cyclohexylamine-induced testicular atrophy in the rat: in vivo and in vitro studies. Exp. Mol. Pathol. 52:1990;155-169.
4. Davis T.R.A., Adler N., Opsahl J.C. Excretion of cyclohexylamine in subjects ingesting sodium cyclamate. Toxicol. Appl. Pharmacol. 15:1969;106-116.
5. Drasar B.S., Renwick A.G., Williams R.T. The role of the gut flora in the metabolism of cyclamate. Biochem. J. 129:1972;881-890.
6. Dorne J.L.C.M., Walton K., Renwick A.G. Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates. Food Chem. Toxicol. 39:2001;681-696.
7. Dorne J.L.C.M., Walton K., Renwick A.G. Human variability in glucuronidation in relation to uncertainty factors for risk assessment. Food Chem. Toxicol. 39:2001;1153-1173.
8. Dorne J.L.C.M., Walton K., Slob W., Renwick A.G. Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? Food Chem. Toxicol. 40:2002;1633-1656.
9. Dorne J.L.C.M., Walton K., Renwick A.G. Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors. Food Chem. Toxicol. 41:2003;201-224.
10. Dorne J.L.C.M., Walton K., Renwick A.G. Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathway-related uncertainty factors. Food Chem. Toxicol. 41:2003;225-245.
11. Dorne J.L.C.M., Walton K., Renwick A.G. Human variability in the renal elimination of foreign compounds and renal excretion-related uncertainty factors for risk assessment. Food Chem. Toxicol. 42:2004;281-304.
12. Dorne J.L.C.M., Walton K., Renwick A.G. Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation). Food Chem. Toxicol. 42:2004;397-421.
13. Eichelbaum M., Hengstmann J.H., Rost H.D., Brecht T., Dengler H.J. Pharmacokinetics, cardiovascular and metabolic actions of cyclohexylamine in man. Arch. Toxicol. 31:1974;243-263.
14. IPCS International Programme on Chemical Safety: Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health-Based Exposure Limits. Environmental Health Criteria. vol. 170:1994;World Health Organization, Geneva, http://www.inchem.org/documents/ehc/ehc/ehc170.htm.
15. IPCS International Programme on Chemical Safety: Principles for Assessment of Risk to Human Health from Exposure to Chemicals. Environmental Health Criteria. vol. 210:1999;World Health Organization, Geneva, http://www.inchem.org/documents/ehc/ehc/ehc210.htm.
16. IPCS International Programme on Chemical Safety: Guidance Document for the use of Chemical-Specific Adjustment Factors (CSAFs) for Interspecies Differences and Human Variability in Dose-Concentration Response Assessment. 2001;World Health Organisation, Geneva. 76 pp http://www.who.int/pcs/ harmon_site/harmonize/guid_doc_CSAFs_page.htm.
17. JECFA, 1982. Toxicological evaluation of certain food additives. WHO Food additives Series, No 17. (Twenty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series, No. 683). http://www.who.int/pcs/jecfa/JECFA_publications.htm ).
18. Price J.M., Biava C.G., Oser B.L., Vogin E.E., Steinfeld J., Ley H.L. Bladder tumors in rats fed cyclohexylamine or high doses of cyclamate and saccharin. Science. 167:1970;1131-1132.
19. Renwick A.G. The metabolism of intense sweeteners. Xenobiotica. 16:1986;1057-1071.
20. Renwick A.G. Intense sweeteners and the gut microflora. Rowland I.R. Role of the Gut Flora in Toxicity and Cancer. 1988;175-206 Academic Press, San Diego.
21. Renwick A.G. Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Addit. Contam. 10:1993;275-305.
22. Renwick A.G., Williams R.T. The metabolites of cyclohexylamine in man and certain animals. Biochem. J. 129:1972;857-867.
23. Roberts A., Renwick A.G. The pharmacokinetics and tissue concentrations of cyclohexylamine in rats and mice. Toxicol. Appl. Pharmacol. 98:1989;230-242.
24. Roberts A., Renwick A.G., Ford G., Creasy D.M., Gaunt I. The metabolism and testicular toxicity of cyclohexylamine in rats and mice during chronic dietary administration. Toxicol. Appl. Pharmacol. 98:1989;216-229.
25. SCF Scientific Committee for Food of the European Commission. Opinion expressed 14th September 1984. http://europa.eu.int/comm/food/fs/sc/scf/ outcome_en.html:1985.
26. SCF Scientific Committee for Food of the European Commission. Opinion on Cyclamic Acid and its Salts (expressed on 14th December 1995). http://europa.eu.int/comm/food/fs/sc/scf/outcome_en.html:1995.
27. SCF Scientific Committee on Food of the European Commission. Opinion on Cyclamic Acid and its Sodium and Calcium salts (expressed on 9th March 2000). http://europa.eu.int/comm/food/fs/sc/scf/outcome_en.html:2000.
28. WHO Principles For The Assessment Of Risk To Human Health From Exposure To Chemicals. Environmenal Health Criteria. vol. 70:1987;World Health Organization, Geneva. http://europa.eu.int/comm/food/fs/sc/scf/outcome_en.html http://www.inchem.org/documents/ehc/ehc/ehc70.htm.
29. Wills J.H., Serrone D.M., Coulston F. A 7-month study of ingestion of sodium cyclamate by human volunteers. Regulat. Toxicol. Pharmacol. 1:1981;163-176.